What is the address of Théfapépsy?

The registered office of Théfapépsy is located at Avenue de la Bourse 1, 1300 Wavre.

Is Théfapépsy still active?

Yes. According to the CBE (31 October 2026) Théfapépsy is active, legal situation “Normale toestand”, started on 17 January 2002.

Is Théfapépsy registered on Peppol?

No, Théfapépsy is currently not registered on the Peppol network.

What is the enterprise number of Théfapépsy?

The enterprise number of Théfapépsy is BE0476692741.

When was Théfapépsy founded?

Théfapépsy was founded on 17 January 2002.

Who are the directors of Théfapépsy?

According to the 2025 annual accounts, the directors of Théfapépsy are: Frederic Jean Goareguer.

Is Théfapépsy a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 17 January 2002; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Théfapépsy make in 2025?

Théfapépsy posted a profit after taxes of € 11,423 in financial year 2025.

What is the revenue of Théfapépsy?

As a small company, Théfapépsy is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 17,649.

Théfapépsy (Private Limited) - Wavre - BE0476692741

Dossier Théfapépsy, printed on 1 November 2026 from databakkes.be/en/0476692741/thefapepsy. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

Théfapépsy from Wavre, company number BE0476692741, closed financial year 2025 with a result of € 11,423 after tax. For that financial year Théfapépsy recorded a gross margin of € 17,649 and equity of € 36,628. Compared with financial year 2024, the result moved from € 2,566 to € 11,423. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 25, 2026.

What it is worth Growing

€ 36,628

▲ 45% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 11,423

▲ € 8,858 vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 27,117

▲ € 26,473 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 24,228.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 1,408

▲ 131% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Taxes

€ 2,309

▲ 245% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 16,634 Gross margin 2022: € 16,634 First fiscal year in the series	€ 24,622 Gross margin 2023: € 24,622 ▲ 48% vs 2022 (€ 16,634) Favourable step	€ 5,457 Gross margin 2024: € 5,457 ▼ 78% vs 2023 (€ 24,622) Unfavourable step	€ 17,649 Gross margin 2025: € 17,649 ▲ 223% vs 2024 (€ 5,457) Favourable step	▲ 223%
Profit after taxes	€ 317 Profit after taxes 2022: € 317 First fiscal year in the series	€ 11,020 Profit after taxes 2023: € 11,020 ▲ € 10,703 vs 2022 (€ 317) Favourable step	€ 2,566 Profit after taxes 2024: € 2,566 ▼ 77% vs 2023 (€ 11,020) Unfavourable step	€ 11,423 Profit after taxes 2025: € 11,423 ▲ € 8,858 vs 2024 (€ 2,566) Favourable step	▲ € 8,858
Equity	€ 12,218 Equity 2022: € 12,218 First fiscal year in the series	€ 22,638 Equity 2023: € 22,638 ▲ 85% vs 2022 (€ 12,218) Favourable step	€ 25,204 Equity 2024: € 25,204 ▲ 11% vs 2023 (€ 22,638) Favourable step	€ 36,628 Equity 2025: € 36,628 ▲ 45% vs 2024 (€ 25,204) Favourable step	▲ 45%
Total debts	€ 12,018 Total debts 2022: € 12,018 First fiscal year in the series	€ 7,958 Total debts 2023: € 7,958 ▼ 34% vs 2022 (€ 12,018) Favourable step	€ 1,878 Total debts 2024: € 1,878 ▼ 76% vs 2023 (€ 7,958) Favourable step	€ 2,846 Total debts 2025: € 2,846 ▲ 52% vs 2024 (€ 1,878) Unfavourable step	▲ 52%
Cash	€ 14,971 Cash 2022: € 14,971 First fiscal year in the series	€ 16,303 Cash 2023: € 16,303 ▲ 9% vs 2022 (€ 14,971) Favourable step	€ 644 Cash 2024: € 644 ▼ 96% vs 2023 (€ 16,303) Unfavourable step	€ 27,117 Cash 2025: € 27,117 ▲ € 26,473 vs 2024 (€ 644) Favourable step	▲ € 26,473
Retained profit	€ -182 Retained profit 2022: € -182 First fiscal year in the series	€ 10,238 Retained profit 2023: € 10,238 ▲ € 10,420 vs 2022 (€ -182) Favourable step	€ 12,804 Retained profit 2024: € 12,804 ▲ 25% vs 2023 (€ 10,238) Favourable step	€ 24,228 Retained profit 2025: € 24,228 ▲ 89% vs 2024 (€ 12,804) Favourable step	▲ 89%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 600 Dividend 2023: € 600 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 600) Unchanged	€ 0 Dividend 2025: € 0 Unchanged (€ 0) Unchanged
Bank debt	€ 6,646 Bank debt 2022: € 6,646 First fiscal year in the series	€ 2,658 Bank debt 2023: € 2,658 ▼ 60% vs 2022 (€ 6,646) Favourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 2,658) Favourable step	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 24,237 Balance sheet total 2022: € 24,237 First fiscal year in the series	€ 30,596 Balance sheet total 2023: € 30,596 ▲ 26% vs 2022 (€ 24,237) Unchanged	€ 27,082 Balance sheet total 2024: € 27,082 ▼ 11% vs 2023 (€ 30,596) Unchanged	€ 39,474 Balance sheet total 2025: € 39,474 ▲ 46% vs 2024 (€ 27,082) Unchanged	▲ 46%

Key figures of Théfapépsy, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Théfapépsy?

What happened at Théfapépsy in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 25, 2026 New annual accounts for financial year 2025: profit of € 11,423 (▲ € 8,858 vs 2024). Source: NBB ↗
2023 Frederic Jean Goareguer became a director. NBB
Jan 17, 2002 Start of the company according to the CBE. KBO

In short

From € 317 profit in 2022 to € 11,423 profit in 2025.

Paid € 15,596 in corporate taxes since 2022.

Best year ever: 2025, with € 11,423 profit.

Paid out € 600 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Frederic Jean Goareguer

Théfapépsy

Behind Théfapépsy is Frederic Jean Goareguer.

Directors

According to the 2025 annual accounts

Frederic Jean Goareguer

Director

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Avenue de la Bourse 1

1300 Wavre

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

Med4Health.be

Arcturus

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0476.692.741
VAT number: BE 0476.692.741
Registered office: Avenue de la Bourse 1, 1300 Wavre
Names & denominations: Théfapépsy
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 17 January 2002
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗